Bd increases domestic production to support u.s. health care need for syringes

Franklin lakes, n.j. , march 21, 2024 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today issued the following statement regarding the march 19, 2024 u.s. food and drug administration (fda) safety communication, which provided important updates on fda's ongoing evaluation of certain plastic syringes: eric borin, president of bd medication delivery solutions said, "bd has the capacity to support additional syringe demand and is further increasing u.s. production to help ensure continuity of patient care.
BDX Ratings Summary
BDX Quant Ranking